Healthtech Investors & VC Firms in Colombia
63 firms in this list, with a median first check of $129K. 21 of them lead rounds. Generated from verified public data and updated continuously.
Nazca
Mexico CityPre-Seed–Late Stage
32 people
Acon Investments
WashingtonSeed–Growth
39 people
Village Capital
WashingtonPre-Seed–Seed$50K – $400K
49 people
IGNIA
Mexico CityPre-Seed–Series A$100K – $5M
20 people
International Finance Corporation
Washington D.C.Series A–Late Stage
24 people
MatterScale Ventures
São PauloPre-Seed–Series A$150K – $750K
29 people
SEAF
WashingtonGrowth$3M – $7M
33 people
Newtopia VC
Buenos AiresPre-Seed–Series A$100K – $1M
12 people
MassChallenge Mexico
BostonPre-Seed–Series A
31 people
Bamboo Capital Partners
LuxembourgSeed–Growth
27 people
Lightrock
LondonSeries A–Growth
21 people
Elevar Equity
BengaluruPre-Seed–Growth$1M – $10M
18 people
U.S. International Development Finance Corporation (DFC)
WashingtonGrowth
30 people
MAYA Capital Ventures
San Paulo, Sao PauloPre-Seed–Series A$100K – $10M
14 people
Yunus Social Business Colombia
BerlinSeed–Growth
33 people
FEMSA Ventures
Mexico CitySeed–Series A$500K – $5M
10 people
Impacta Latam VC
SantiagoPre-Seed–Series A$100K – $500K
15 people
Southern Cross Group
SantiagoGrowth–Late Stage
15 people
IG4 Capital
São Paulo
23 people
HTwenty
MiamiPre-Seed–Series A$100K – $1M
7 people
Salkantay Ventures
Pre-Seed–Series A
14 people
Amador Holdings
Panama CitySeed–Growth
9 people
K20 Fund
Valley StreamSeed–Growth$100K – $2.5M
4 people
Benchstrength Partners
New YorkPre-Seed–Seed
5 people
Related lists
Investors & VC Firms in North America (12952)Investors & VC Firms in United States (11990)Investors & VC Firms in Europe (5859)Investors & VC Firms in Global (4787)AI & Machine Learning Investors & VC Firms (4629)Fintech Investors & VC Firms (4588)SaaS Investors & VC Firms (4239)Healthtech Investors & VC Firms (4227)Enterprise Software Investors & VC Firms (4136)Crypto & Web3 Investors & VC Firms (3986)
Data sourced from public filings and firms' own websites — see our methodology.








































































































